Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
18 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Caffeine“
Suchtreffer
Begriffe & Kennungen
Kisqali · 4.5 · Co-administration of caffeine (CYP1A2 substrate) with multiple doses of Kisqali (400 mg) increased the caffein
Eintrag öffnenLeflunomide Zentiva (previously Leflunomide Winthrop) · 4.5 · Effect on caffeine (CYP1A2 substrate) Repeated doses of A771726 decreased mean Cmax and AUC of caffeine (CYP1A
Eintrag öffnenLeflunomide Zentiva (previously Leflunomide Winthrop) · 4.5 · Effect on caffeine (CYP1A2 substrate) Repeated doses of A771726 decreased mean Cmax and AUC of caffeine (CYP1A
Eintrag öffnenLeflunomide Zentiva (previously Leflunomide Winthrop) · 4.5 · Effect on caffeine (CYP1A2 substrate) Repeated doses of A771726 decreased mean Cmax and AUC of caffeine (CYP1A
Eintrag öffnenLeflunomide medac · 4.5 · Effect on caffeine (CYP1A2 substrate) Repeated doses of A771726 decreased mean Cmax and AUC of caffeine (CYP1A
Eintrag öffnenLeflunomide ratiopharm · 4.5 · Effect on caffeine (CYP1A2 substrate) Repeated doses of A771726 decreased mean Cmax and AUC of caffeine (CYP1A
Eintrag öffnenLitfulo · 4.5 · Multiple doses of 200 mg once daily ritlecitinib increased the AUCinf and Cmax of caffeine, a CYP1A2 substrate
Eintrag öffnenPeyona (previously Nymusa) · 4.5 · 5 Although few data exist on interactions of caffeine with other active substances in preterm newborn infants,
Eintrag öffnenPeyona (previously Nymusa) · 4.5 · Cytochrome P450 1A2 (CYP1A2) is the major enzyme involved in the metabolism of caffeine in humans. Therefore,
Eintrag öffnenPeyona (previously Nymusa) · 4.5 · Inter-conversion between caffeine and theophylline occurs in preterm newborn infants. These active substances
Eintrag öffnenPeyona (previously Nymusa) · 4.8 · The known pharmacology and toxicology of caffeine and other methylxanthines predict the likely adverse reactio
Eintrag öffnenRapiscan · 4.5 · Methylxanthines Methylxanthines (e.g., caffeine and theophylline) are non-specific adenosine receptor antagoni
Eintrag öffnenRayvow · 4.5 · Daily dosing of lasmiditan did not alter the PK of midazolam, caffeine, or tolbutamide, which are substrates o
Eintrag öffnenRubraca · 4.5 · CYP1A2 substrates Rucaparib showed no effect on Cmax of caffeine while moderately increasing AUCinf of caffein
Eintrag öffnenVipdomet · 4.5 · 8 In clinical studies, alogliptin had no clinically relevant effect on the pharmacokinetics of caffeine, (R)-w
Eintrag öffnenVipidia · 4.5 · 5 In clinical studies, alogliptin had no clinically relevant effect on the pharmacokinetics of caffeine, (R)-w
Eintrag öffnencaffeine
Eintrag öffnencaffeine citrate
Eintrag öffnen